myeloproliferative_neoplasm_a_diagnostic_approach_to_bone_marrow_evaluation.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation Clinical suspicion of myeloproliferative neoplasm Consistent with...
Learn more about how immunology testing at Mayo Clinic Laboratories can reveal genetic associations to disorders that impact the immune system.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Identifying disease biomarkers with phage immunoprecipitation sequencing - Insights
Mayo Clinic’s Advanced Diagnostics Laboratory researchers are using phage immunoprecipitation sequencing to discover new serological biomarkers for autoimmune diseases.
erythrocytosis_evaluation_testing_algorithm.pdf
03/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Erythrocytosis Evaluation Testing Algorithm Testing begins with: PVJAK / Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing...
New Tests Launched in October - Insights
In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.